article thumbnail

What to Expect During a Primary Care Visit

Mesa Family Physician

Doctor appointment length PCP appointment duration If you have multiple issues to discuss, be sure to mention that when scheduling so the clinic can allot enough time. What to Expect During a Primary Care Visit Visiting a primary care provider for the first time can bring up many questions. What does the doctor do first?

article thumbnail

How to Improve Care for Patients With Multiple Chronic Conditions

Physician's Weekly

Regularly, specialists have to ask patients to explain why their PCPs referred them, and few specialists still send “courtesy” notes to PCPs after a consultation. They should also try to obtain the results of any exams, tests, or consultations that aren’t yet in the chart. Conduct a daily morning huddle.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EMS Intervention to Reduce Falls: Carmen Quatman and Katie Quatman-Yates

GeriPal

Going into patient’s homes was eye opening. There were trip hazards, loose carpets, some people were hoarders. And yet, after assisting the older adult to their feet, the EMS providers would leave. Their job was done. It’s not surprising that the number of repeat calls for falls is alarmingly high. Alex: I think this is a first.

Community 114
article thumbnail

DEA Proposes Additions to Longstanding Precursor Chemical Special Surveillance List

FDA Law Blog

In determining updates to the Special Surveillance List, DEA consulted multiple levels of law enforcement, forensic laboratory authorities, intelligence groups, drug profiling programs and international organizations. 21 U.S.C. § 39,479, (June 16, 2023). DEA’s notice of proposed updates is available here.

article thumbnail

DEA Cranks Out Updated Special Surveillance List and Proposed Regulatory Actions

FDA Law Blog

The newly updated Surveillance List includes chemicals, materials and equipment used in the manufacture, production and distribution of currently abused synthetic drugs like fentanyl, amphetamine, methamphetamine, PCP, LSD, ketamine and others. 21 U.S.C. § 842(a)(11). 21 U.S.C. § 23,711 (June 4, 2025).